MIAMI,Nov. 1, 2022 – PRESS RELEASE – Ayr Wellness Inc., a leading vertically integrated multistatecannabis operator, announced the opening of two new retail stores in Florida,located in Daytona Beach and Lake Worth, as well as the expansion of LEVIAwater-soluble cannabis tinctures to its Florida retail menus.

Ayr’snewest stores in Daytona Beach and Lake Worth join more than 50 other retaillocations throughout the state. Through this robust retail footprint, Florida’srapidly growing community of more than 761,000 qualified patients have accessto Ayr’s growing menu of cannabis products.

“Weare excited to see the results from the progress we’ve made in Florida sinceacquiring Liberty Health Sciences in 2021. We’ve opened more than 20 newlocations, with our store count now at 52, and have introduced several brandsfrom our national portfolio to the market,” Ayr founder and CEO JonathanSandelman said. “On our mission to produce the highest quality cannabis atscale, Florida has been instrumental in bringing that vision to life.”

Atall Liberty Health Sciences locations, patients can now enjoy LEVIAwater-soluble cannabis tinctures, the latest addition to its menus followingthe recent introduction of hydrocarbon-extracted concentrates brand HAZE, aswell as the award-winning premium whole flower brand, Lost in Translation(LIT).

LEVIAtinctures come in three unique offerings: the indica Dream, the hybridCelebrate, and the sativa Achieve. Featuring high bioavailability and 300 milligramsof THC per bottle, LEVIA tinctures are water-soluble, allowing for flexibledosing and easy mixing with water and other beverages based on consumers’preference. The tinctures are fast-acting, providing a unique intended effectfor the consumer within minutes.

Nowoperating in eight states throughout the country, Ayr continues to reaffirm itscommitment to the state of Florida, employing more than 800 people across itsheadquarters office in Miami, 52 retail locations throughout the state, a 745,000-square-footcultivation facility in Gainesville and other field and corporate positions.

AUSTIN, Texas, Oct. 31, 2022 – PRESS RELEASE - Libra Design, LLC (Libra) announced the official launch of its horticulture lighting design services and Mid-Flux (MF) and High-Flux (HF) LED Modules for the Controlled-Environment Agriculture (CEA) industry, specifically for commercial indoor and greenhouse farming. Based on a customizable platform and a transparent, function-based pricing model, the new LED systems are designed and priced to ensure farmer cultivation and financial success. 

“LED technology has taken greenhouse growing to new levels of production and transformed vertical farming from science fiction to a modern reality,” said Travis Williams, Libra co-founder & CEO. “Yet today’s LED systems are still cost-prohibitive and inadequately designed for most crop producers. Our goal with the launch of the Libra Design Mid-Flux and High-Flux LED Modules is to remove the financial barrier to CEA by providing indoor and greenhouse growers access to premium LED technology without the premium price tag.” 

Designed for CEA and Certified to the Latest Safety Standards

The Libra MF and HF LED modules are specifically engineered for indoor and greenhouse farming environments where dust, water, chemicals, and workers are present, and are now certified to the latest UL 8800 standard for horticulture lighting equipment and systems. With an all-metal construction, passive cooling, and a wet-location IP66 rating, the LED modules are designed for years of efficient, maintenance-free operation reinforced by passing the construction and testing requirements for the Supplement SA to UL 8800. 

“Decades of experience in LED systems, optics, and horticulture lighting went into the development of our Mid-Flux and High-Flux LED systems,” said Dung Duong, Libra co-founder and CTO. “Being certified to the UL 8800 standard and having passed the requirements set forth in the new Supplement SA, affirms our commitment to developing a no-compromise lighting platform which delivers the exact performance, reliability and affordability growers need to succeed in today’s challenging industry.” 

A Unique Approach to Horticulture Lighting 

Colorado State University’s (CSU) Cannabinoid Research Center (CRC) has been operating for a full year, with its work so far largely focused on identifying and quantifying various cannabinoids, laying the foundation to support clinical studies.

CSU received a $1.5 million donation in early 2020 from an alumna who wanted to create a research center dedicated to studying the chemical compounds in hemp. The CRC was born and now operates in collaboration with Panacea Life Sciences, a Colorado-based cannabinoid research and certified GMP manufacturing company.

RELATED: Inside Colorado State University’s Plans for a Cannabinoid Research Center

The CRC aims to solve industry-wide issues and gain a better understanding of how cannabinoids work in the body. In the past year, researchers have discovered how to remove common contaminants from hemp products and purify cannabinoids that are present  in low concentrations in the hemp plant, as well as created the foundation for future clinical studies.

“You see people who say such-and-such a cannabinoid has this effect, and then there’s no data,” CRC Director Melissa Reynolds says. “You don’t know how much, you don’t know which cannabinoid [and] you don’t know which applications. So, that’s what we’re really working on, is getting the science right.”

More provisional business licensees are coming online in Mississippi’s medical cannabis program.

State officials recently outlined licensing figures and other updates for the state’s medical cannabis industry during an Oct. 27 press conference.

Kris Jones Adcock, director of the Mississippi Medical Cannabis Program, said the state has issued provisional licenses to 47 cultivators, 138 dispensaries, eight processors, three waste disposal businesses, two testing labs and four transporters. As of Oct. 3, Mississippi had announced 38 cultivation provisional approvals, according to Memphis, Tenn., NBC affiliate Action News 5.

Additionally, Adcock said Mississippi’s medical cannabis program now has 406 patients, 117 practitioners who can provide medical cannabis recommendations, and 491 work permits for people to work in the cannabis industry. The state had approved 367 work permits with 50 in processing as of Oct. 3, per Action News 5.

Adcock and two other state officials—Dr. Dan Edney, Mississippi’s state health officer and a physician, and Jim Craig, senior deputy and director of health protection at the Mississippi State Department of Health—said state officials are working diligently to prevent product from being diverted to the illicit cannabis market.

 “We’re not going to be able to get that to zero,” Edney said of diversion. “But we’re getting it as low as we can through our regulatory authority based on the statutory conditions that we’re given …. I have full confidence that we’re doing more than a reasonable job of protecting against diversion, and we will continue to do the very best of our ability.”

The Alabama Medical Cannabis Commission (AMCC) is implementing a statewide seed-to-sale tracking system for medical cannabis to ensure product quality and safety.

AMCC External Affairs Director Brittany Peters told 1819 News that the tracking system will allow "the Commission to track cannabis throughout cultivation, transportation, processing, testing and dispensing of medical cannabis."

RELATED: Alabama Regulators Send Medical Cannabis License Applications to Business Hopefuls

The system will help hold licensees accountable and will help track how much cannabis is produced, processed, and sold in the state, Peters said.

The commission is also implementing a system for state and local law enforcement to validate medical cannabis cards and enforce driver license suspensions for patients "who have been recommended a daily dosage of medical cannabis that exceeds 75 milligrams THC," according to 1819 News.

The AMCC is in the process of rolling out the state's medical program, which should be operational by late next year, according to the commission's timeline.

Ohio Secretary of State Frank LaRose recently entertained the idea of making it more difficult for Ohioans to pass an adult-use cannabis legalization ballot measure in 2023.

The state’s chief elections officer told The Plain Dealer last week that he thinks the Ohio Legislature should consider raising the bar to require a 60% supermajority for voters to pass constitutional amendments on the ballot instead of the simple majority currently required.

LaRose’s recommendation comes five months after initiative organizers from the Coalition to Regulate Marijuana Like Alcohol (CRMLA) struck an agreement with state lawmakers to suspend their 2022 ballot campaign and aim for 2023. Included in the settlement, the 135,000-plus certified signatures that CRMLA advocates gathered will be preserved for next year.

“We have casinos and medical marijuana and all manner of things that now have found their way into the Ohio Constitution,” LaRose told Plain Dealer reporters Oct. 27 during an endorsement interview that also included Chelsea Clark, his Democratic challenger for the Nov. 8 election.

Those comments came despite LaRose voting in favor of House Bill 523, which legalized medical cannabis in Ohio, during his time as a state senator in 2016.

“And so, I think the signature threshold may be one thing to look at,” LaRose said. “But another one might be, it takes a supermajority vote in the Legislature to refer a question to the ballot; why not require a supermajority vote of the citizens in order to pass a constitutional amendment?”

DETROIT, Oct. 31, 2022 – PRESS RELEASE – Gage Cannabis, subsidiary of TerrAscend Corp. and a leading high-quality cannabis brand and operator in Michigan, announced its fourth social equity grant recipient, Midwest CannaNurses (MCN). MCN is a Detroit-based minority-owned holistic health and wellness education consulting company dedicated to health advocacy, education and inclusion with a focus on cannabis as an alternative therapy.

"Midwest CannaNurses is extremely grateful to receive Gage's generous grant, which will aid our mission to educate the community about cannabis as an alternative therapy for health and wellness," said Biyyiah Lee, co-founder and CEO of Midwest CannaNurses. "With this contribution, we will be able to provide professional development for nurses and allied health professionals and expand our community outreach efforts by holding more educational seminars for the public. We're glad to see companies like Gage seeking opportunities to support organizations that uplift diverse communities, and this social equity grant will enable us to continue advocating for safe and informed cannabis use.”

Founded in 2020 by a group of licensed nurses who recognized their unique position and duty to normalize cannabis as medicine, Midwest CannaNurses has strived to close the current gap in the public's knowledge through education efforts including their "Outgrow The Stigma" initiative. Across Michigan, MCN offers consulting services with a focus on cannabis as medicine, and provides education on topics such as dosing titration, safe consumption, routes of administration and Individualized CannaPlans.

"Gage and TerrAscend are proud to award our social equity grant to Midwest CannaNurses, a valuable organization focused on advocating for safe, effective cannabis use while demanding destigmatization and decriminalization in communities of color," said Mike Finos, president and EVP of Operations at Gage Cannabis. "Biyyiah and MCN are an exceptionally talented group of health experts providing education and resources to patients and medical professionals throughout Michigan. We look forward to supporting MCN as it continues to eliminate disparities of access and improve their patients' quality of life for years to come."

The grant recipient's launch event, Midwest CannaNurses Presents: Let's #OutgrowTheStigma: Healthcare, Cannabis, and Metro Detroit, is free and open to the public and will be held on Nov. 3, 2022, at the Durfee Innovation Center (2470 Collingwood St.). AJ Williams of the Michigan Chronicle will host and moderate an educational panel of industry leaders, including James Tate, Detroit City Council president pro tem; Biyyiah Lee, MCN co-founder and CEO; and a retail cannabis representative. Register for the event here.

For more information about Gage's social equity program, visit www.gagesocialequity.com.

Various hemp cannabinoid products in the marketplace may not have the same cannabinoid content as their labels state, and they may contain harmful contaminants, sources tell Cannabis Business Times.

As CBT has reported, “lab shopping” is an issue that occurs in state-legal cannabis markets. There is evidence that some cannabis producers look to work with labs to inflate THC potency results to meet consumer knowledge and demand for high-THC products, and some producers search for labs that will provide favorable test results for microbiological contaminants, pesticides or residual solvents, according to CBT’s sources.

But lab shopping is also happening in the hemp industry, with some producers searching for lab partners that will deflate hemp THC potency results to below the 0.3% delta-9 THC federal limit, mislabel content of other cannabinoids—such as CBD, CBG, delta-8, delta-10, THC-O acetate or hexahydrocannabinol (HHC)—and/or not test for contaminants.

Josh Wurzer is president and co-founder of cannabis testing laboratory SC Labs, which operates hemp and cannabis testing labs in several states. He says a portion of hemp producers ask labs for lower potency figures so they can meet the federal 0.3% delta-9 THC limit. He says SC Labs doesn’t honor these requests, but some other labs do.

“So, you have [state-legal cannabis] customers calling and saying, ‘Hey, I need higher THC results,’ or implying that, and going to another laboratory that will give to them,” Wurzer says. “But then you also have your hemp customers saying, ‘I need lower THC results to pass my 0.3% threshold for hemp products.’”

Roger Brown is founder and president of ACS Laboratory in Sun City Center, Fla., which tests hemp from 48 states and 16 countries, as well as Florida medical cannabis. He also spoke with CBT about potency inflation in state-legal cannabis markets, but says “lab shopping is quite rampant in the hemp industry, as well.”

Mississippi regulators are taking disciplinary action against Mockingbird Cannabis, LLC, a medical cannabis grower that allegedly used plastic- and cloth-covered greenhouse structures to begin cultivation operations.

The structures, commonly referred to as hoophouses, violate Mississippi’s medical cannabis law, which requires indoor cultivation.

As Cannabis Business Times previously reported, some of Mississippi’s other medical cannabis growers commented on Mockingbird’s alleged violations during the Board of Health’s public meeting Oct. 12. The Department of Health said at the time that it planned to respond with “corrective actions,” allowing licensees that violate state regulations time to fix their infractions.

However, department officials announced Oct. 27 that Mockingbird, one of the largest medical cannabis operators in the state, must now destroy roughly $1 million worth of plants and temporarily cease operations until structural improvements are made at one of its sites, according to a Mississippi Today report.

Mockingbird had allegedly been growing medical cannabis at a secondary site roughly 12 miles from its main operations near Raymond, the news outlet reported, and the company had not been registering the plants in Mississippi’s seed-to-sale tracking system.

The U.S. Sentencing Commission (USSC) estimates that more than 6,500 Americans are eligible to receive pardons under President Joe Biden’s federal cannabis policy reform plan.

Biden announced earlier this month a sweeping, three-part plan to pardon all federal simple cannabis possession offenses, urge all state governors to pardon state-level offenses of simple cannabis possession, and initiate a review of how cannabis is scheduled under federal law.

RELATED: Biden's Order to Review Cannabis 'Truly Historic,' But What's at Stake?

The USCC has since issued a news advisory announcing its estimates on who may be impacted by the federal pardons.

The USCC’s analysis, which includes federal data dating back to 1992, estimates that 6,577 U.S. citizens will receive forgiveness under Biden’s pardon.

Beverly, Mass. (October 24, 2022) – Real Isolates LLC, a private Greater Boston area biotech company is pleased to announce that it has been issued a patent by the United States Patent and Trademark Office for a novel method used to extract cannabinoids and other compounds from cannabis smoke. The extracted oil created by this method, sold, and licensed under the brand name Smokenol™, is rich in common and rare cannabinoids and enables a new category of oral, topical, and inhaled cannabis products.

“Our solventless method is not just a simpler and safer alternative to CO2 or hydrocarbon extraction.” said Michiel Westerkamp, Real Isolates CEO. “The majority of experienced cannabis users prefer the effects of cannabis smoke to conventional edibles. This patented method allows hemp and cannabis product manufacturers to deliver edible, topical, and inhalable products that combine convenience, duration, and dose consistency with effects similar to those from smoking.”

The cannabinoid composition of the cannabis plant is transformed by the high heat necessary to generate smoke. Conventional cannabis extracts use low temperatures and do not contain the richer diversity and balance of cannabinoids found in Smokenol™ smoke extracts and cannabis smoke.

Real Isolates licenses this intellectual property to product manufacturers. Examples of hemp-derived topicals and tinctures can be found at www.ProfoundNaturals.com.

At least eight states will have new governors in 2023: Arizona, Arkansas, Hawaii, Maryland, Massachusetts, Nebraska, Oregon and Pennsylvania.

Overall, 36 gubernatorial seats are being contested on Nov. 8 ballots, with the winner of each race gaining executive power to advance and pursue new and revised state policies and programs, including medical and adult-use cannabis.

From executive orders to budget proposals and vetoes, current and former governors have already steered, blocked or impacted cannabis legalization efforts in some fashion since California voters first approved Proposition 215 for a medical program in 1996, and since Colorado and Washington voters first passed adult-use ballot measures in 2012.

While legalization in any form is what’s at stake in states like Idaho, Kansas and Nebraska, which have some of the most restrictive cannabis policies in the nation, government officials in states like California and Oregon continue to seek new strategies and regulations to combat illicit activities and help struggling businesses in mature markets.

Furthermore, gubernatorial races in Arkansas, Maryland and South Dakota, where voters will also be casting ballots on adult-use cannabis measures, hold major implications for program rollouts should those measures pass. Missouri and North Dakota also have 2022 adult-use ballot measures, but no governor races are unfolding there this election cycle.

South Dakota perhaps provides a telling example of how one state executive has exercised her power to avert reform. Incumbent Republican Gov. Kristi Noem issued an executive order in January 2021, asserting that voter-approved Amendment A (adult-use cannabis) was unconstitutional, and launched a taxpayer-funded lawsuit challenging the 2020 ballot measure, paving way for the state’s Supreme Court to eventually strike it down. Voters could find redemption in 2022.

The Colorado Department of Revenue (DOR) and the Colorado Department of Public Health and Environment (CDPHE) issued a Health and Safety Advisory Oct. 26 over flower potentially contaminated with mold.

Officials have identified “potentially unsafe levels of total yeast and mold and aspergillus” on medical cannabis flower produced by SDJ, LLC, which does business in Colorado as The Living Rose.

According to the advisory, harvest batches of medical cannabis produced by SDJ were not submitted for testing in accordance with state law, and when the batches were tested, the results showed total yeast, mold and aspergillus levels above the acceptable limits.

State officials advise consumers to check the labels on their medical cannabis products for the below license and harvest batch numbers, which indicate that the products are impacted by the recall. Consumers who have the affected products should destroy them or return them to the dispensary where they were purchased for proper disposal.

Shannon Gray, a spokesperson for the DOR, declined to comment on the specifics of the ongoing investigation, but told Cannabis Business Times that “the facts of each investigation (including aggravating and mitigating factors) all determine the overall recommendation for an agency action once an investigation concludes.”

Major cannabis policy reform could be coming to the U.S. Virgin Islands under legislation unveiled this week.

Sen. Janelle Sarauw introduced two bills Oct. 24—one to legalize adult-use cannabis and another to expunge past cannabis-related convictions, according to The St. Thomas Source.

“It has been a very cumbersome process to get these bills to where they are today,” Sauraw, who is running alongside gubernatorial candidate Sen. Kurt Vialet to replace Gov. Albert Bryan Jr. and Lt. Gov. Tregenza Roach in the Nov. 8 election, told the news outlet.

Bryan proposed his version of an adult-use cannabis legalization bill, the Cannabis Use Act, in 2019 and again in 2020, The St. Thomas Source reported.

Bryan’s re-election campaign scolded Sarauw earlier this month for not introducing her cannabis legislation earlier, after she promised to file the bills in 2021, according to the news outlet.

A University of Kentucky (UK) professor reported to the Interim Joint Committee on Health, Welfare, and Family Services this week and revealed plans for research and trials that will be conducted at the UK’s Cannabis Center.

RELATED: University of Kentucky Opens Medical Cannabis Research Center

The research center was authorized under a bill that Gov. Andy Beshear signed into law in April. The legislation was backed by key lawmakers who were opposed to a medical cannabis legalization bill, which stalled earlier this year.

RELATED: 'There Will Be Some Actions Forthcoming:' Kentucky Governor Reaffirms Plans to Legalize Medical Cannabis Through Executive Action

Dr. Shanna Babalonis, the director of the research center, presented a variety of planned, controlled studies to the committee Oct. 26, according to a local WKYT report.

In its second operation, the Unified Cannabis Enforcement Taskforce (UCETF) served 13 search warrants between Oct. 18 and Oct. 19 on unlicensed indoor cultivation operations near Los Angeles and seized an estimated retail value of roughly $8 million of illicit cannabis.

Gov. Gavin Newsom created the taskforce, led by the Department of Cannabis Control (DCC), the California Department of Fish and Wildlife (CDFW), the Governor's Office of Emergency Services (OES), and several other partners, "to eliminate the number of illicit cannabis operations in the state, which has been affecting state-legal businesses," Cannabis Business Times previously reported.

The UCETF eradicated 7,503 illicit cannabis plants and more than 936 pounds of processed illegal cannabis flower, according to a news release from CDFW.

In addition, the California Department of Toxic Substances Control also discovered high levels of toxic chemicals at some locations. 

"Criminal cannabis operators, like those we enforced against in this operation, jeopardize the health of their workers by using toxic chemicals to help fertilize indoor cultivations that undercut the legal market and present safety risks to consumers," said Nicole Elliott, DCC director. "While DCC works hard to support the transition of legacy operators into the legal market, we have zero tolerance for this behavior and will work with our partners across state, local, and the federal government to shut it down."

The Los Angeles Department of Water and Power also uncovered safety code violations at all 13 sites and has since disconnected the power at all locations, according to the release.

Portland (ME) – PRESS RELEASE – Today marks the official launch of ERG Strategies, LLC, a consulting firm set to advise governments at all levels and national clients operating in the complex cannabis space. The firm is driven by its founder and former top cannabis regulator for the state of Maine, Erik Gundersen.

“I’m excited to share my experiences and expertise with government entities and cannabis businesses nationwide,” says Gundersen. “I look forward to contributing to sustainable, equitable and responsible cannabis markets on a larger scale.”

Gundersen’s time in cannabis policy started as Senior Policy Advisor in the Maine Speaker’s Office and as liaison to the Legislature’s Joint Select Committee on Marijuana Legalization and Implementation, the committee credited with drafting the Maine Legalization Act, which serves as the framework for Maine’s now burgeoning adult-use cannabis program.

In February 2019, Maine Gov. Janet Mills tapped Gundersen to establish the Office of Cannabis Policy and launch the state’s adult-use cannabis program. Under Gundersen’s leadership, the Office of Cannabis Policy successfully ushered in the first set of program rules, scaled the office, built out systems and processes, and began accepting license applications at the end of 2019. Maine’s adult use cannabis program launched in 2020 amid the COVID pandemic.

“I’m incredibly proud of everything we accomplished during my time leading the Office of Cannabis Policy,” adds Gundersen. “Cannabis regulators are a small group of the most dedicated public servants imaginable. I look forward to continuing my working in cannabis alongside this amazing group and private companies as well.”

(SANTA ROSA, Calif.) – PRESS RELEASE – Cultivation, propagation and post-harvest workers at Flora Terra Cannabis have voted overwhelmingly to join Teamsters Local 665. They are the first group of cannabis workers to join the Teamsters under the California Agricultural Labor Relations Act in Northern California.

“Congratulations to our newest members, who stood strong and worked together to make this happen,” said Tony Delorio, Local 665 Principal Officer. “California agriculture workers have already gotten great wages, strong benefits, and a united voice on the job with a Teamster contract. We don’t expect things to be any different with this company when we begin bargaining.”

“Cannabis generates more revenue in California than any other state in the country,” said Peter Finn, Teamsters Food Processing Division Director. “We look forward to ensuring that an equitable share of the money generated from this industry goes to those who are most responsible for the success of these companies.”

“We’re doing this because we know that with a Teamster contract, cannabis can be a fulfilling career that workers can stay in for their entire lives if they want to,” said Anthony Benavides, a worker at the Flora Terra facility. “We’re part of a massive movement of people working to guarantee that the cannabis industry creates thousands of jobs that provide families with middle-class prosperity.”

Teamsters Local 665 represents over 5,000 members throughout the Bay Area in a wide variety of industries. For more information, go to https://www.teamsters665.org/.

PHOENIX, Arizona, Oct. 27, 2022 — PRESS RELEASE — TILT Holdings Inc., a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced the Pennsylvania launch of "H" by Ricky Williams, the former NFL player's medical cannabis brand. The purpose-driven brand will be distributed to dispensaries throughout the commonwealth of Pennsylvania for medical cannabis patients through TILT subsidiary Standard Farms.

Motivated by his own personal journey with medical cannabis and healing, Williams' brand, more widely known as Highsman, launched in November 2021 to inspire greatness and promote wellness in athletes and sports fans. The brand is now available in five states, with Pennsylvania marking its second state launch in partnership with TILT. The initial product collection offering includes flower 8ths in:

"This brand line, more specifically marijuana, has profoundly and positively impacted my life," Williams said. "I introduced these products to break through the stigma of marijuana and improve access to those seeking to be the best versions of themselves. Thanks to our partnership with TILT, we can introduce even more patients to the benefits and healing properties of medical marijuana through our brand."

"TILT's differentiated brand-partner model allows us to collaborate with some of the most innovative and impactful brands in the U.S. and introduce them to new markets," said Gary Santo, TILT CEO. "I am proud to be working with Ricky to bring this authentic brand to patients in Pennsylvania."

Pennsylvania patients can find "H" by Ricky Williams branded products throughout the state via the TILT wholesale channel.

BOCA RATON, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- PRESS RELEASE -- Jushi Holdings Inc., a vertically integrated, multi-state cannabis operator, announced it has debuted its newly formulated vegan and gluten-free Tasteology Fruit Chews in Massachusetts, and expects to roll out the new product line in Virginia, Ohio and Nevada in Q1 2023.

Made with the finest real fruit purées by Ponthier, and crafted by Jushi’s Director of Manufacturing and Bravo’s Top Chef: Just Desserts finalist, Matthew Petersen, along with Jushi’s Product Development Team, Tasteology Fruit Chews are now available in three new varieties—Blood Orange Boost, Blueberry Calm and Passion Raspberry Balance—at Nature’s Remedy dispensaries in Tyngsborough and Millbury, Mass., and will continue to roll out to partner dispensaries in the coming months.